SUPPORT (Supportive Understanding and Patient-centered Partnership to Optimize Renal Treatment) (SUPPORT)
Enrolling By Invitation
18-100 years
All
Phase
N/A
150 participants needed
1 Location
Brief description of study
The research study is being conducted to test how providing trauma-informed care training to health care providers and support from a community health worker to patients may affect health outcomes for people with lower kidney functioning, also known as “chronic kidney disease.” Chronic kidney disease can be caused by health conditions such as diabetes and high blood pressure.
Detailed description of study
Participation includes:
- Completing two 30-45 minute surveys over the phone, six months apart
- Patients receiving care from Division of General Internal Medicine primary care practices also have a 50-50 chance of receiving support from a community health worker for six months. Community health workers can help with things like figuring out how to pay for medications, arranging transportation to medical appointments, or creating healthy habits.
Eligible individuals who enroll and complete both surveys will be compensated $100 for participating.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Chronic Kidney Disease
-
Age: Between 18 Years - 100 Years
-
Gender: All
Penn Medicine patients are eligible for this study if they:
- Receive care from one of the following primary care practices:
- Penn Internal Medicine University City
- Edward S. Cooper Internal Medicine
- Penn Family Medicine University City
- Penn Family Care
- Have a diagnosis of chronic kidney disease (Stage 3b, 4, or 5)
- Insured by Medicaid/Medicare or uninsured
You are not eligible for this study if you:
- Are currently working with a community health worker
- Are currently receiving dialysis
- Have had a kidney transplant
Updated on
25 Oct 2024.
Study ID: 855188
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu
For cancer trials contact EmergingMed: 1-855-216-0098 or PennCancerTrials@emergingmend.com
